Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer

Clinical trial NCT05646550 · RECRUITING

Trial details

NCT number: NCT05646550
Sponsor: University Hospital Tuebingen
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Recurrent

Start date: 2022-11-11
Primary completion: 2025-12-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.